(104 days)
No
The summary describes a system for regional anesthesia and pain management using electrical stimulation to assist with needle and catheter placement, but there is no mention of AI or ML technology.
Yes
The product's intended use clearly states it is for "delivery of medication for regional anesthesia and pain management," which are therapeutic applications.
No
The device is indicated for delivery of medication and to assist in placement of the catheter using electrical stimulation. Its purpose is interventional (medication delivery and placement assistance), not diagnostic.
No
The device description explicitly lists physical components like cannulas, catheters, and a locking cap, indicating it is a hardware-based medical device.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for "delivery of medication for regional anesthesia and pain management." This involves direct interaction with the patient's body for therapeutic purposes.
- Device Description: The device components (cannula, catheter, locking cap) are designed for delivering substances into the body.
- Lack of IVD Characteristics: There is no mention of the device being used to examine specimens derived from the human body (like blood, urine, tissue) to provide information for diagnosis, monitoring, or screening.
IVD devices are specifically designed for testing samples outside the body to gain diagnostic information. This device is designed for direct patient intervention.
N/A
Intended Use / Indications for Use
The E-Cath STIM acc. Tsui System is indicated for delivery of medication for regional anesthesia and pain management. Route of administration may be intraoperative, percutaneous, or perineural. To assist the physician pinpoint the area of application an electrical stimulus can be applied to the conduction needle removal, to assist the physician pinpoint conduction catheter placement, an electrical stimulus can be applied to the conduction catheter tip via the catheter adapter.
The E-Cath STIM acc. Tsui System is contraindicated for the epidural space.
Product codes (comma separated list FDA assigned to the subject device)
CAZ, BSP, BSO
Device Description
The Over-the-needle (OTN) Catheter Systems are available in different designs with cannula and catheter in different sizes. The system includes: SonoPlex cannula, permanent cannula, E-Cath catheter, locking cap.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Benchmarking tests were conducted to verify compliance with international recognized standards.
-
Needle: stability test bending rigidity:
- Reason for test: The needle has to demonstrate bending stability and resistance against breakage in order to resist forces reasonably assumed to the needle in situ under the defined intended use.
- Procedure of test: Defined by international standard EN ISO 9626: Stainless steel needle tubing for manufacture of medical devices.
- Pass/Fail criteria: ≤0.48mm under an applied force of 15N by a span width of 17.5mm.
- Results: The bending rigidity of the subject/predicate/reference device's needles (as they are the same) is less than 0.46mm.
- Conclusion: Substantially Equivalent. In compliance.
-
Needle: stability test bonding to hub:
- Reason for test: The needle has to demonstrate stability at the bonding of the hub in order to resist forces reasonably assumed to be applied to the needle in situ under the defined intended use.
- Procedure of test: Defined by international standard EN ISO 7864: Sterile hypodermic needles for single use.
- Pass/Fail criteria: The acceptance criterion for the bond between hub and needle tube (pull-off force) is ≥44N.
- Results: For the subject/predicate/reference device's needles (as they are the same) a force significantly higher than the target value has to be applied.
- Conclusion: Substantially Equivalent, in compliance.
-
Needle: Penetration force:
- Reason for test: The needles have to demonstrate less trauma when applied with the patient under the intended use.
- Procedure of test: According to international European standard EN 13097.
- Pass/Fail criteria: None, objective comparison only.
- Results: The subject/predicate/reference device's needles (as they are the same) show appropriate penetration/ insertion forces.
- Conclusion: Substantially Equivalent, in compliance.
-
Catheter: Leak Tightness:
- Reason for test: The catheter and its connections have to demonstrate stability and tightness in order to resist forces reasonably assumed to be applied to the catheter in situ under the defined intended use.
- Procedure of test: Defined by international European standard DIN EN 1618.
- Pass/Fail criteria: Not defined by the standard, defined through internal protocols based on risk assessment and clinical evaluation.
- Results: The subject/predicate/reference device's catheters (as they are the same) meet the acceptance criterion.
- Conclusion: Substantially Equivalent, in compliance.
-
Catheter: tensile strength:
- Reason for test: The catheter has to demonstrate stability and tensile strength in order to resist forces reasonably assumed to be applied to the catheter in situ under the defined intended use.
- Procedure of test: Defined by international European standard DIN EN 10555-1.
- Pass/Fail criteria: Not defined by the standard, defined through internal protocols based on risk assessment and clinical evaluation.
- Results: The subject/predicate/reference device's catheters (as they are the same) meet the acceptance criterion.
- Conclusion: Substantially Equivalent, in compliance.
-
Catheter: Flow Rate:
- Reason for test: The catheter has to demonstrate a stable flow rate in order to perform properly in situ under the defined intended use.
- Procedure of test: Defined by international European standard DIN EN 10555-1.
- Pass/Fail criteria: Not defined by the standard, defined through internal protocols based on risk assessment and clinical evaluation.
- Results: The subject/predicate/reference device's catheters (as they are the same) meet the acceptance criterion and have proven to supply appropriate flow rates.
- Conclusion: Substantially Equivalent, in compliance.
Sterilization:
- Validated according to: ISO 11135-1 Overkill Approach (1 sublethal cycle, 2 half cycle, 1 full cycle).
- Residuals: EO and ECH are in compliance with ISO 10993-7.
- Limits for Residuals: 25ppm = 25μg(g/device) of Ehyleneoxide (EO); 25ppm = 25μg/(g/device) Ethylene chlorhvdrine.
- Limit for Pyroburden/endotoxine: 0.06 EU/ml and 2.15 EU/device acc. to FDA GUIDELINE ON VALIDATION OF LIMULUS AMEBOCYTE LYSATE TEST AS AN END-PRODUCT ENDOTOXIN TEST FOR HUMAN AND ANIMAL PARENTERAL DRUGS, BIOLOGICAL PRODUCTS, AND MEDICAL DEVICES - Issued 12/1987.
Shelf Life:
- Validation: Efficacy of sterile product's lifecycle validated using predicate device, reference device, and worst case devices.
- Sterility tests: Performed on worst case devices with similar characteristics made from identical material after 5 years, found to be sterile. Sterile barrier system is efficient.
- Performance tests: Essential performance (LUER connection, stability of bonding connections, catheter's tensile strength, needle's bending rigidity) tested with real time aged needles and catheters made from identical material employing identical processes, found to work properly. No decrease in performance after 5 years.
- Set Shelf-life: 5 years.
Biocompatibility:
- Compliance: All products comply with ISO 10993-1, 5th edition.
- Tests conducted: In vitro Cytotoxicity_ISO 10993-5, Irritation_ISO 10993-10, In vitro Haemolysis Test on static conditions ISO 10993-04, Acute Systemic Toxicity ISO 10993-11, Test for delayed type hypersensitivity:ISO10993-10, Reverse Mutation Assay_ISO 10993-03, Implantation ISO 10993-06, Implantation Histopatology ISO 10993-06. All accomplished successfully.
Technology Characteristics:
- EN ISO 9626: Stainless steel needle tubing for manufacture of medical devices. Cannula tubing fulfills requirements.
- EN ISO 7864: Sterile hypodermic needles for single use. Cannulas comply with requirements.
- EN 13097: Hypodermic needles. Penetration force tested, in compliance with predicate device.
- DIN EN 10555-1: Intravascular catheters - sterile and single use catheters - Part 1: General requirements. Catheter fulfills requirements.
- DIN EN 1618: Catheters other than intravascular catheters - Test methods for common properties. Catheter fulfills requirements.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K152952 E-Cath, K033018 StimuLong
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
K111374, K013041, K062900, K082164
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 868.5140 Anesthesia conduction kit.
(a)
Identification. An anesthesia conduction kit is a device used to administer to a patient conduction, regional, or local anesthesia. The device may contain syringes, needles, and drugs.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, with the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG" in blue, and then the word "ADMINISTRATION" in a smaller font size, also in blue.
December 29, 2020
PAJUNK GmbH Medizintechnologie Christian Quass Director Regulatory Affairs Karl-Hall-Str. 1 Geisingen, Baden-Wuerttemberg 78187 Germany
Re: K202699
Trade/Device Name: E-Cath STIM acc. Tsui Regulation Number: 21 CFR 868.5140 Regulation Name: Anesthesia Conduction Kit Regulatory Class: Class II Product Code: CAZ, BSP, BSO Dated: December 4, 2020 Received: December 14, 2020
Dear Christian Quass:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal
1
statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Todd Courtney Assistant Director DHT1C: Division of ENT, Sleep Disordered Breathing, Respiratory and Anesthesia Devices OHT1: Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K202699
Device Name
E-Cath STIM acc. Tsui
Indications for Use (Describe)
The E-Cath STIM acc. Tsui System is indicated for delivery of medication for regional anesthesia and pain management. Route of administration may be intraoperative, percutaneous, or perineural. To assist the physician pinpoint the area of application an electrical stimulus can be applied to the conduction needle removal, to assist the physician pinpoint conduction catheter placement, an electrical stimulus can be applied to the conduction catheter tip via the catheter adapter.
The E-Cath STIM acc. Tsui System is contraindicated for the epidural space.
Type of Use (Select one or both, as applicable)
| ☑ Prescription Use (Part 21 CFR 801 Subpart D) | ☐ Over-The-Counter Use (21 CFR 801 Subpart C) |
|---|---|
| ------------------------------------------------------------------------------------ | ----------------------------------------------------------------------------------- |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/3 description: The image shows the word "PAJUNK" in a teal color. The font is sans-serif and the letters are bold. There is a registered trademark symbol to the right of the letter K.
Special 510(k) Summary as required by 21 CFR 807.92(c).
Date of Preparation: 2020-12-27
Document Control Number: K202699
Special 510(k) owner:
PAJUNK® GmbH Medizintechnologie Karl-Hall-Str. 1 78187 Geisingen Baden-Wuerttemberg, Germany Fon: +49(0)7704-9291-586 Fax: +49(0)7704-9291-605 Establishment Registration Number: 9611612
Submitter Information/ production site:
PAJUNK® GmbH Medizintechnologie Karl-Hall-Str. 1 78187 Geisingen Baden-Wuerttemberg, Germany Fon: +49(0)7704-9291-586 Fax: +49(0)7704-9291-605 Establishment Registration Number: 9611612
Contact:
Christian G. H. Quass Director Requlatory Affairs, Safety Officer Patricia Weisbrod Regulatory Affairs Manager Fon: +49(0)7704-9291-586 Fax: +49(0)7704-9291-605 E-Mail: christian.quass@pajunk.com E-Mail: patricia.weisbrod@pajunk.com
Regulatory
USA Contact:
PAJUNK® MEDICAL SYSTEMS 6611 Bay Circle, Suite 140 Norcross, GA 30071 Phone +1 (888) 9PAJUNK (72-5865) Fax +1 (678) 514-3388
Establishment Registration Number: 3004076349
Contact
Marco Wohniq President PAJUNK® Medical Systems L.P. Phone: (770) 493-6832 Direct: (470) 448-4070 (770) 757-2449 Cell: Fax: (678) 514-3388 E-Mail: marco.wohnig@pajunk-usa.com
4
Special 510(k): Device Modification Premarket Notification Submission
Image /page/4/Picture/3 description: The image shows the word "PAJUNK" in a sans-serif font. The letters are a teal color, and there is a registered trademark symbol to the right of the letter "K". The word is displayed horizontally and is the main focus of the image.
| Device Information: | |
|---|---|
| Device Name: | E-Cath STIM acc. Tsui |
| Components: | SonoPlex cannula |
| E-Cath StimuLong catheter | |
| Locking cap | |
| Injection tube | |
| permanent cannula | |
| Bacterial filter | |
| Sterilization method: | Ethylene Oxide |
| disposable device supplied sterile to the end | |
| user | |
| Contract Sterilizer: | Sterigenics Germany GmbH |
| Kasteler straße 45 | |
| 65203 Wiesbaden | |
| Germany, Hessen | |
| Establishment Registration Number: | |
| 3002807090 | |
| Document Control Number | K202699 |
| Device Name: | E-Cath STIM acc. Tsui |
| Classification Name: | Anesthesia Conduction Kit |
| Classification Reference: | 21 CFR 868.5140 |
| Product Code: | CAZ |
| Subsequent Classification Name #1: | Anesthesia Conduction Needle |
| Subsequent Classification Reference #1: | 21 CFR 868.5150 |
| Subsequent Product Code #1: | BSP |
| Subsequent Classification Name #2: | Anesthesia Conduction Catheter |
| Subsequent Classification Reference #2: | 21 CFR 868.5120 |
| Subsequent Product Code #2: | BSO |
| Establishment Registration Number: | 9611612 |
| Regulatory Class: | II |
| Panel: | Anesthesiology |
| Predicate Device: | K152952 E-Cath |
| Second Predicate Device: | K033018 StimuLong |
5
Components of the device system already cleared by sponsor´s 510(k)s or exempt or class I:
SonoPlex cannula (K111374) StimuLong catheter (K033018, K013041. K062900) Locking cap (K082164 et al.) Injection tube (K082164 et altera) Permanent cannula (K033018. K082164 et al.)
PAJUNK® GmbH Medizintechnologie is submitting this Special 510(k) for a modification of the Over-the-needle (OTN) Catheter System, brand name "E-Cath", intended to be brand-named E-Cath STIM acc. Tsui.
It is considered a Class II medical device as defined in 21 CFR §868.5140 anesthesia conduction kit, product code CAZ (Subsequent Codes: 21 CFR §868.5120 catheter, conduction, anesthetic, product code BSO and 21 CFR §868.5150 Anesthesia conduction needle, product code BSP.
The intended use as well as the individual components this system consist of have been cleared in different 510(k)s sent in earlier by the sponsor and shall be combined under a new device name. So the E-Cath K152952 shall be equipped with a stimulation catheter (in K152952 the catheter described is a non-stimulation catheter but the stimulation catheter in K152952 is already optionally listed) as it is described in the 510(k)s for the second predicate device StimuLong K033018.
The intended use of the E-Cath STIM acc. Tsui shall be extended to one more specific use as defined in an earlier 510(k) which serves as reference device.
In order to make the clearance status of the subject device – E-Cath STIM acc. Tsui – more obvious, sponsor decided to compile the data in one individual standalone Special 510(k) describing the modifications more clearly.
The technique – over the needle – is rarely identified in submissions with identical indications for use. Usually it is not mentioned whether the technique of placing a catheter is "over the needle" or "through the needle". This detail in application method does not make any difference in evaluating safety, effectiveness and efficacy of the device itself from the technological point of view.
So substantial equivalence of the modifications is based on earlier submissions by the sponsor and verified through Design verification process.
6
Image /page/6/Picture/3 description: The image shows the word "PAJUNK" in a sans-serif font. The letters are a teal color, and there is a registered trademark symbol to the right of the letter K. The letters are bold and spaced closely together.
Indications for use subject device:
The E-Cath STIM acc. Tsui System is indicated for delivery of medication for regional anesthesia and pain management. Route of administration may be intraoperative, percutaneous, or perineural. To assist the physician pinpoint the area of application an electrical stimulus can be applied to the conduction needle. After needle removal, to assist the physician pinpoint conduction catheter placement, an electrical stimulus can be applied to the conduction catheter tip via the catheter adapter.
The E-Cath STIM acc. Tsui System is contraindicated for the epidural space.
Device Description:
The Over-the-needle (OTN) Catheter Systems are available in different designs with cannula and catheter in different sizes. The system includes: SonoPlex cannula, permanent cannula, E-Cath catheter, locking сар.
Predicate Device:
The predicate device for the E-Cath STIM is K152952 E-Cath manufactured by PAJUNK® GmbH Medizintechnologie.
Second Predicate Device:
The second predicate device for the E-Cath STIM is StimuLong K033018 manufactured by PAJUNK® GmbH Medizintechnologie.
Determination methods and results of Substantial Equivalence Determination:
Intended Use
Intended Use Subject Device
The E-Cath STIM acc. Tsui System is indicated for delivery of medication for regional anesthesia and pain management. Route of administration may be intraoperative, percutaneous, or perineural. To assist the physician pinpoint the area of application an electrical stimulus can be applied to the conduction needle. After needle removal, to assist the physician pinpoint conduction catheter placement, an electrical stimulus can be applied to the conduction catheter tip via the catheter adapter.
The E-Cath STIM acc. Tsui System is contraindicated for the epidural space.
Intended Use K152952 E-Cath (Predicate Device)
The Over-the-needle (OTN) Catheter System is indicated for delivery of medication for regional anesthesia and pain management. Route of administration may be intraoperative, percutaneous, or perineural. The Over-the-needle (OTN) Catheter System is contraindicated for the epidural space.
Intended Use K033018 StimuLong (Second Predicate Device)
The Pajunk Stimulong Plus Catheter Sets are intended for delivery of continuous conduction anesthesia of peripheral nerves and plexus for up to 72 hours. Continuous delivery is accomplished using the conduction catheter. To assist the physician pinpoint the area of application an electrical stimulus can be applied to the conduction needle and after placement of the conduction catheter to its tip via the catheter adapter.
Discussion
The wording has been updated, but the general intended use remains the same. In addition K033018 has a technical amendment for electrical position control which is state of the art and which shall be added to the subject device s intended use. This amendment which is the reason for this modification of the device and the 510(k) is both, state of the art as well as cleared by FDA in earlier 510(k)s.
Conclusion: neutral modification
7
Image /page/7/Picture/3 description: The image shows the word "PAJUNK" in a sans-serif font. The letters are a teal color, and the registered trademark symbol is located in the upper right corner of the "K". The word is horizontally oriented and centered.
Side-by-side comparison table
| Characteristics | Subject Device
E-Cath STIM acc. Tsui
Pajunk® GmbH Medizintechnologie | Predicate Device
K152962 E-Cath
E-Cath Over-the-needle (OTN) Catheter System
Pajunk® GmbH Medizintechnologie | Predicate Device
K033018 StimuLong
Pajunk® GmbH Medizintechnologie | Result of comparison, if necessary with rationale |
|-----------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------|
| Biocompatibility | | ISO 10993-1 compliant material & set components | | Identical |
| Labeling | | 21 CFR and European Medical Devices Directive compliant | | identical |
| Packaging | Packed in a hard blister package consisting
out of GGG PET foil and Tyvek (heat sealed)
or in a foil bag with tyvek. | Packed in a hard blister package consisting
out of GGG PET foil and Tyvek (heat sealed)
or in a foil bag with tyvek. | Packed in a hard blister
package consisting out
of GGG PET foil and
Tyvek (heat sealed) or
in a foil bag with tyvek. | identical |
| Overall design: Set
components | Needle: SonoPlex with stimulation and permanent
cannula
Stimulation Catheter
Injection tube
Retaining clip
Filter
FixoLong or FixoCath | Needle: SonoPlex with stimulation and permanent
cannula
Catheter
Injection tube
Retaining clip
Filter
FixoLong or FixoCath | Needle: SonoPlex with
stimulation and permanent
cannula
Stimulation Catheter
Injection tube
Retaining clip
Filter
FixoLong or FixoCath | Difference: Stimulation
catheter cleared for the
intended use in
K033018 instead of
non-stimulation
catheter |
| Technology | Catheter-over needle | Catheter-over-needle | Catheter through
needle | Technologically
equivalent technique,
both state of the art |
| technical
specifications | Stainless steel needle and Polyamide catheter | Stainless steel needle and Polyamide catheter | Stainless steel needle
and Polyamide catheter | identical |
| principles of
operation | Penetrate skin using needle, position control
Dual Guidance, Placement of catheter,
position control Dual Guidance, injection of
anesthetic agent | Penetrate skin using needle, position control
Dual Guidance, Placement of catheter,
position control ultrasound, injection of
anesthetic agent | Penetrate skin using
needle, position control
Dual Guidance,
Placement of catheter,
position control Dual
Guidance, injection of
anesthetic agent | Enhancement of
technique by adding
stimulation for dual
guidance |
| Characteristics | Subject Device
E-Cath STIM acc. Tsui
Pajunk® GmbH Medizintechnologie | Predicate Device
K152962 E-Cath
E-Cath Over-the-needle (OTN) Catheter
System
Pajunk® GmbH Medizintechnologie | Predicate Device
K033018 StimuLong
Pajunk® GmbH
Medizintechnologie | Result of comparison,
if necessary with
rationale |
| Materials | Stainless steel and plastics | Stainless steel and plastics | Stainless steel and
plastics | identical |
| Feature:
Echogenicity | Cannula & Catheter | Cannula & Catheter | none | Identical, technological
enhancement in subject
device compared to
second predicate
device |
| Feature: Stimulation | Cannula and catheter | Cannula | Cannula and catheter | equivalent |
| Feature:
Connectivity | ISO80369-6 (NRFit®)and 80369-7 (LUER) Connectivity | LUER Connectivity | LUER Connectivity | Identical, made fit with
state of the art |
R&D Regulatory Resp. SAS Resp. CQ/PAW
8
Image /page/8/Picture/3 description: The image shows the word "PAJUNK" in a sans-serif font. The color of the text is a shade of green. There is a registered trademark symbol to the right of the letter "K".
The specifications for the stimulation catheters – material, indications for use, diameter 20G – are absolutely the same.
| NAME OF COMPONENT | MATERIAL | BODY CONTACT |
|---|---|---|
| E-Cath STIM catheter | ||
| Tubing | PA | Direct, limited |
| Stimulating knob | 2.0771 gold plated | Direct, limited |
| Wire | 1.4310 stainless steel | Indirect, limited |
| Glue | Loctite | No contact at all |
| StimuLong K033018 | E-Cath Stim K202699 | Discussion | |
|---|---|---|---|
| material | Polyamide, transparent | Polyamide, transparent | Identical |
| diameter | 20G | 20G | Identical |
9
Image /page/9/Picture/3 description: The image shows the word "PAJUNK" in a sans-serif font. The letters are a teal color. There is a registered trademark symbol to the right of the K.
| StimuLong K033018 | E-Cath Stim K202699 | Discussion | |
|---|---|---|---|
| length | 500mm, 600mm, 900mm | 68mm | Made fit to kit, no effect on |
| indications for use, safety or | |||
| effectiveness | |||
| (Negligible less dead space | |||
| volume) | |||
| 82mm | |||
| 101mm | |||
| 114mm | |||
| distal tip design | central orifice | central orifice | |
| proximal tip design | central orifice | central orifice (lateral opening | |
| where the indwelling cannula | |||
| begins) | Equivalent; the lateral opening as | ||
| cleared in K152952 does not | |||
| have an effect on safety or | |||
| effectiveness | |||
| radiopacity | radiopaque stripe (tungsten) | radiopaque stripe (tungsten) | Identical |
| echogenicity | standard | standard | Identical |
| marking | 360° circumflex | 360° circumflex | Identical |
| marking material | TPU 73 black | TPU 73 black | Identical |
| packaging | container | PE foil bag | Equivalent |
| stimulation | yes, via golden stimulating knob | ||
| and stimulating stylet | yes, via golden stimulating knob | ||
| and stimulating stylet | Identical | ||
| fixation | stimulating clamping adapter | stimulating cannula hub | Identical |
10
Image /page/10/Picture/3 description: The image shows the word "PAJUNK" in a teal color. The letters are large and bold, and the word is centered in the image. There is a registered trademark symbol to the right of the letter K.
Furthermore the benchmarking tests described below have been conducted for the subject device as they are conducted for the predicate device and its reference devices in order to verify compliance with international recognized standards.
Needle: stability test bending rigidity
Reason for test. The needle has to demonstrate bending stability and resistance against breakage in order to resist forces reasonably assumed to the needle in situ under the defined intended use
Procedure of test: The test procedure is defined by international standard EN ISO 9626: Stainless steel needle tubing for manufacture of medical devices.
Pass/ Fail criteria: According to the standard the acceptance criterion of bending rigidity for the cannula is ≤0,48mm under an applied force of 15N by a span width of 17,5mm.
Results: The bending rigidity of the subject/predicate/reference device's needles (as they are the same) is less than 0,46mm.
Conclusion: Substantially Equivalent. In compliance
Needle: stability test bonding to hub
Reason for test. The needle has to demonstrate stability at the bonding of the hub in order to resist forces reasonably assumed to be applied to the needle in situ under the defined intended use.
Procedure of test. The test procedure is defined by international standard EN ISO 7864: Sterile hypodermic needles for single use
Pass/ Fail criteria: The acceptance criterion for the bond between hub and needle tube (pull-off force) is ≥44N.
Results: For the subject/predicate/reference device's needles (as they are the same) a force significantly higher than the target value has to be applied.
Conclusion: Substantially Equivalent, in compliance
11
Image /page/11/Picture/3 description: The image shows the word "PAJUNK" in a teal color. The letters are large and bold, and the word is horizontally oriented. There is a registered trademark symbol to the right of the letter "K".
Needle: Penetration force
Reason for test: The needles have to demonstrate less trauma when applied with the patient under the intended use.
Procedure of test: According to international European standard EN 13097.
Pass/ Fail criteria: -none- objective comparison only.
Results: The subject/predicate/reference device's needles (as they are the same) show appropriate penetration/ insertion forces.
Conclusion: Substantially Equivalent, in compliance
Catheter: Leak Tightness
Reason for test: The catheter and its connections have to demonstrate stability and tightness in order to resist forces reasonably assumed to be applied to the catheter in situ under the defined intended use
Procedure of test: The test procedure is defined by international European standard DIN EN 1618.
Pass/ Fail criteria: The pass-fail-criteria are not defined by the standard and are defined through internal protocols based on risk assessment and clinical evaluation.
Results: The subject/predicate/reference device's catheters (as they are the same) meet the acceptance criterion.
Conclusion: Substantially Equivalent, in compliance
Catheter: tensile strength
Reason for test: The catheter has to demonstrate stability and tensile strength in order to resist forces reasonably assumed to be applied to the catheter in situ under the defined intended use.
Procedure of test: The test procedure is defined by international European standard DIN EN 10555-1.
Pass/ Fail criteria: The pass-fail-criteria are not defined by the standard and are defined through internal protocols based on risk assessment and clinical evaluation.
Results: The subject/predicate/reference device's catheters (as they are the same) meet the acceptance criterion.
Conclusion: Substantially Equivalent, in compliance
12
Image /page/12/Picture/3 description: The image shows the word "PAJUNK" in a sans-serif font. The color of the text is a shade of teal. There is a registered trademark symbol to the right of the letter K. The text is horizontally oriented and centered.
Catheter: Flow Rate
Reason for test: The catheter has to demonstrate a stable flow rate in order to perform properly in situ under the defined intended use.
Procedure of test: The test procedure is defined by international European standard DIN EN 10555-1.
Pass/ Fail criteria: The pass-fail-criteria are not defined by the standard and are defined through internal protocols based on risk assessment and clinical evaluation.
Results: The subject/predicate/reference device's catheters (as they are the same) meet the acceptance criterion and have proven to supply appropriate flow rates.
Conclusion: Substantially Equivalent, in compliance
Sterilization
The contract sterilizer and the sterilizing process are identical to the process and sterilizer used for all PAJUNK® - manufactured devices which are already cleared for market or exempt.
Sterilization parameters are
| SAL | 10-6 |
|---|---|
| Type of gas | Ethylene Oxide 99,99% |
| Exposure time | 300 min. |
| Aeration method | evacuation |
| 2 airwashes | |
| Aeration period | residual EtO-gas is removed in circulating |
| air at 40° C (±5) for at least 48h |
Sterilization has been validated according to ISO 11135-1 Overkill Approach (1 sublethal cycle, 2 half cycle, 1 full cycle)
Residuals of EO and ECH are in compliance with ISO 10993-7.
Cleaning and Sterilization method, which ensures an SAL of 10° as well as compliance with limits for chemical burden, bioburden (i.e. LAL) and EtO-residuals as well as shelf life have been validated and are safe and effective.
The limits listed below are met by each device:
Limits for Residuals: 25ppm = 25μg(g/device) of Ehyleneoxide (EO); 25ppm = 25μg/(g/device) Ethylene chlorhvdrine
Limit for Pyroburden/ endotoxine: 0,06 EU/ml and 2,15 EU/ device acc. to FDA GUIDELINE ON VALIDATION OF LIMULUS AMEBOCYTE LYSATE TEST AS AN END-PRODUCT ENDOTOXIN TEST FOR HUMAN AND ANIMAL PARENTERAL DRUGS, BIOLOGICAL PRODUCTS, AND MEDICAL DEVICES - Issued 12/ 1987
13
Image /page/13/Picture/3 description: The image shows the word "PAJUNK" in a sans-serif font. The letters are a teal color, and the "R" symbol is located in the upper right corner of the "K". The word is centered and takes up most of the image.
Shelf Life
Efficacy of sterile product's lifecycle has been validated using the predicate device and the reference device as well as worst case devices.
Sterility tests have been performed using worst case devices with similar characteristics made from identical material after 5 years. The devices were found to be sterile after 5 years, the sterile barrier system is efficient.
Performance of the essential performance of the device (LUER connection, stability of bonding connections, catheter's tensile strength, needle's bending rigidity) has been tested with real time aged needles and catheters made from identical material employing identical processes and those are found to work properly. There is no decrease in performance after 5 years.
Shelf-life is set to 5 years.
Biocompatibility:
All products comply with ISO 10993-1, 5th edition.
The components the system is assembled from have proven biocompatibility in former 510(k) files also containing the individual components.
The tests listed below have been conducted and accomplished successfully by components and worst case devices:
- In vitro Cytotoxicity_ISO 10993-5
- . Irritation_ISO 10993-10
- In vitro Haemolysis Test on static conditions ISO 10993-04
- . Acute Systemic Toxicity ISO 10993-11
- Test for delayed type hypersensitivity:ISO10993-10
- . Reverse Mutation Assay_ISO 10993-03
- Implantation ISO 10993-06 .
- . Implantation Histopatology ISO 10993-06
Therefore and based upon sterilization and residuals validation the kits also are considered to be biocompatible.
14
Image /page/14/Picture/3 description: The image shows the word "PAJUNK" in a sans-serif font. The letters are a teal color. There is a registered trademark symbol to the right of the letter K.
Technology Characteristics:
Besides bench testing recognized standards are applicable for the subject device. Compliance is claimed for the standards listed below:
EN ISO 9626: Stainless steel needle tubing for manufacture of medical devices.
The cannula tubing of the cannula included in the subject device fulfills the requirements according to EN ISO 9626. Technological characteristics like material, surface finish, cleanliness, limits for acidity and alkalinity and size designation are complied with.
Regarding the requirement of bending rigidity and breaking resistance the cannula tubes are tested according to the standard (Annex C and D).
According to the standard the acceptance criterion of the bending rigidity for the cannula is ≤ 0,48mm. The applied force was 15N by a span width of 17,5mm. The bending rigidity of the tested cannulas is less than 0,46mm. Therefore the cannula meets this acceptance criterion.
The acceptance criterion of the breaking resistance is: not to break.
During the test the cannula is bended an angle, which is defined in the standard based on to the cannula size, for 20 periods. Means the cannula is bended in two directions. The tested cannulas did not break during the test.
Therefore the cannula meets this acceptance criterion.
The cannulas fulfill all the requirements of EN ISO 9626.
EN ISO 7864: Sterile hypodermic needles for single use
The cannulas used comply with the requirements according to EN ISO 7864. Technology characteristics like Cleanliness, Limits for acidity or alkalinity, Limits for extractable metals, size designation, needle hub, sheath, tolerances, patency of lumen, freedom from defects, lubricant, needle point, packaging and labeling are in compliance.
Regarding the requirement of bond between hub and needle tube the cannula is tested according to the standard.
The acceptance criterion for the bond between hub and needle tube (pull-off force) is ≥44N.
Therefore the cannula meets the acceptance criterion.
The cannulas fulfill all the requirements of EN ISO 7864.
EN 13097: Hypodermic needles
The penetration force of the cannula is tested according to the standard (Annex D). The standard does not include acceptance criteria but is meant to provide an objective test method.
Compared to the predicate device PAJUNK's needles are in compliance.
15
Image /page/15/Picture/3 description: The image shows the word "PAJUNK" in a teal color. The letters are large and bold, and the font is sans-serif. There is a registered trademark symbol to the right of the letter K. The background is white.
DIN EN 10555-1: Intravascular catheters - sterile and single use catheters - Part 1: General requirements
The catheter fulfills the requirements of the standard DIN EN 10555-1. Technology characteristics like X-ray visibility, biocompatibility, surface, hub, lateral openings, catheter tip, size designation, packaging and labelling are met.
Tensile force, tightness and flow rate are tested according to the standard.
The standard does not give an acceptance criterion for the tensile force.
Due to this, PAJUNK® set the acceptance criterion for this to an internally defined acceptable value to be met without tear off. The catheters of the E-Cath Systems meet the acceptance criterion.
For the test on leak tightness, the catheter system has to be tight for a defined period of time as well as a defined pressure. All systems are tight during the test.
Also for the flow rate no acceptance criterion is given specification of PAJUNK® catheters regarding the flow rate is internally defined by the sponsor based on risk management and clinical evaluation. The flow rate of the tested E-Cath catheter meets the acceptance criterion.
The requirement of high-performance injection does not apply because the catheter is not intended for high-performance injection.
The catheters fulfill all the requirements.
DIN EN 1618: Catheters other than intravascular catheters - Test methods for common properties
The catheter of the E-Cath System fulfills the requirements of the standard DIN EN 1618. Requirements like tensile properties, tightness, flow rate as well as the safety of connectors are tested according to the standard.
The standard does not give an acceptance criterion for the tensile force.
Due to this, PAJUNK® set the acceptance criterion for this to an internally defined mustvalue without tear off.
The catheters of the E-Cath System meet the acceptance criterion.
For the test on tightness, the catheter system has to be tight for a defined period of time as well as a defined pressure. All systems are tight during the test.
Also for the flow rate no acceptance criterion is given.
The specification of PAJUNK® catheters regarding the flow rate is defined as internal must-value. The flow rate of the tested E-Cath catheter meets the acceptance criterion.
The catheters and needles fulfill all the requirements for the essential technological characteristics.
As proven in earlier Submissions of the predicate device as well as of the reference devices basic fundamental technological characteristics as described above are met.
16
Image /page/16/Picture/3 description: The image shows the word "PAJUNK" in a sans-serif font. The letters are a teal color. There is a registered trademark symbol to the right of the "K".
Conclusion:
The comparison between the predicate devices and the subject device of this submission as well as the validated sterilization process and the results of the standard bench testing demonstrates that the subject devices are the same as the predicate device and the reference devices and identical in technical description to those devices already cleared for market and therefore demonstrated to be as safe and effective as the legal predicate devices.
Based on the clinical evaluation, the biocompatibility testing and the bench testing conducted, safe performance of the E-Cath STIM is demonstrated.